Literature DB >> 23432340

Photothermal therapy of cancer cells mediated by blue hydrogel nanoparticles.

Taeyjuana Curry1, Tamir Epstein, Ron Smith, Raoul Kopelman.   

Abstract

AIM: The aim of this study was to investigate in vitro the utility of biologically compatible, nontoxic and cell-specific targetable hydrogel nanoparticles (NPs), which have Coomassie® Brilliant Blue G dye (Sigma-Aldrich, MO, USA) covalently linked into their polyacrylamide matrix, as candidates for photothermal therapy (PTT) of cancer cells. MATERIALS &
METHODS: Hydrogel NPs with Coomassie Brilliant Blue G dye covalently linked into their polyacrylamide matrix were fabricated using a reverse micelle microemulsion polymerization method and were found to be 80-95 nm in diameter, with an absorbance value of 0.52. PTT-induced hyperthermia/thermolysis was achieved at 37°C using an inexpensive, portable, light-emitting diode array light source (590 nm, 25 mW/cm(2)). RESULTS &
CONCLUSION: Hydrogel NPs with Coomassie Brilliant Blue G dye linked into their polyacrylamide matrix are effective in causing PTT-induced thermolysis in immortalized human cervical cancer cell line (HeLa) cells for varying NP concentrations and treatment times. These multifunctional particles have previously been used in cancer studies to enable delineation, for glioma surgery and in photoacoustic imaging studies. The addition of the PTT function would enable a three-pronged theranostic approach to cancer medicine, such as guided tumor surgery with intra-operative photoacoustic imaging and intra-operative PTT.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23432340      PMCID: PMC3758451          DOI: 10.2217/nnm.12.190

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  24 in total

1.  Methylene blue-conjugated hydrogel nanoparticles and tumor-cell targeted photodynamic therapy.

Authors:  Hoe Jin Hah; Gwangseong Kim; Yong-Eun Koo Lee; Daniel A Orringer; Oren Sagher; Martin A Philbert; Raoul Kopelman
Journal:  Macromol Biosci       Date:  2011-01-10       Impact factor: 4.979

Review 2.  Inorganic nanoparticles for cancer imaging and therapy.

Authors:  Huang-Chiao Huang; Sutapa Barua; Gaurav Sharma; Sandwip K Dey; Kaushal Rege
Journal:  J Control Release       Date:  2011-06-22       Impact factor: 9.776

3.  Hydrogel nanoparticles with covalently linked coomassie blue for brain tumor delineation visible to the surgeon.

Authors:  Guochao Nie; Hoe Jin Hah; Gwangseong Kim; Yong-Eun Koo Lee; Ming Qin; Tanvi S Ratani; Panagiotis Fotiadis; Amber Miller; Akiko Kochi; Di Gao; Thomas Chen; Daniel A Orringer; Oren Sagher; Martin A Philbert; Raoul Kopelman
Journal:  Small       Date:  2012-01-09       Impact factor: 13.281

4.  Near infrared luminescent oxygen nanosensors with nanoparticle matrix tailored sensitivity.

Authors:  Yong-Eun Koo Lee; Elyse E Ulbrich; Gwangseong Kim; Hoejin Hah; Christen Strollo; Wenzhe Fan; Rajan Gurjar; SangMan Koo; Raoul Kopelman
Journal:  Anal Chem       Date:  2010-10-15       Impact factor: 6.986

Review 5.  Brain cancer diagnosis and therapy with nanoplatforms.

Authors:  Yong-Eun Lee Koo; G Ramachandra Reddy; Mahaveer Bhojani; Randy Schneider; Martin A Philbert; Alnawaz Rehemtulla; Brian D Ross; Raoul Kopelman
Journal:  Adv Drug Deliv Rev       Date:  2006-09-28       Impact factor: 15.470

6.  The brain tumor window model: a combined cranial window and implanted glioma model for evaluating intraoperative contrast agents.

Authors:  Daniel A Orringer; Thomas Chen; Dah-Luen Huang; William M Armstead; Benjamin A Hoff; Yong-Eun L Koo; Richard F Keep; Martin A Philbert; Raoul Kopelman; Oren Sagher
Journal:  Neurosurgery       Date:  2010-04       Impact factor: 4.654

7.  Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.

Authors:  Jeffrey Hrkach; Daniel Von Hoff; Mir Mukkaram Ali; Elizaveta Andrianova; Jason Auer; Tarikh Campbell; David De Witt; Michael Figa; Maria Figueiredo; Allen Horhota; Susan Low; Kevin McDonnell; Erick Peeke; Beadle Retnarajan; Abhimanyu Sabnis; Edward Schnipper; Jeffrey J Song; Young Ho Song; Jason Summa; Douglas Tompsett; Greg Troiano; Tina Van Geen Hoven; Jim Wright; Patricia LoRusso; Philip W Kantoff; Neil H Bander; Christopher Sweeney; Omid C Farokhzad; Robert Langer; Stephen Zale
Journal:  Sci Transl Med       Date:  2012-04-04       Impact factor: 17.956

8.  Assessment of the In Vivo Toxicity of Gold Nanoparticles.

Authors:  Yu-Shiun Chen; Yao-Ching Hung; Ian Liau; G Steve Huang
Journal:  Nanoscale Res Lett       Date:  2009-05-08       Impact factor: 4.703

9.  In vitro characterization of a targeted, dye-loaded nanodevice for intraoperative tumor delineation.

Authors:  Daniel A Orringer; Yong-Eun L Koo; Thomas Chen; Gwangseong Kim; Hoe Jin Hah; Hao Xu; Shouyan Wang; Richard Keep; Martin A Philbert; Raoul Kopelman; Oren Sagher
Journal:  Neurosurgery       Date:  2009-05       Impact factor: 4.654

10.  Size-dependent cytotoxicity of gold nanoparticles.

Authors:  Yu Pan; Sabine Neuss; Annika Leifert; Monika Fischler; Fei Wen; Ulrich Simon; Günter Schmid; Wolfgang Brandau; Willi Jahnen-Dechent
Journal:  Small       Date:  2007-11       Impact factor: 13.281

View more
  3 in total

1.  Hydrogel Nanoparticles with Thermally Controlled Drug Release.

Authors:  Teppei Shirakura; Taylor J Kelson; Aniruddha Ray; Antonina E Malyarenko; Raoul Kopelman
Journal:  ACS Macro Lett       Date:  2014-06-12       Impact factor: 6.903

2.  Intracellular Photodynamic Activity of Chlorin e6 Containing Nanoparticles.

Authors:  Thomas Hopkins; Rahil Ukani; Raoul Kopelman
Journal:  Int J Nanomed Nanosurg       Date:  2016-11-17

Review 3.  Possible role of nanocarriers in drug delivery against cervical cancer.

Authors:  Swati Gupta; Manish K Gupta
Journal:  Nano Rev Exp       Date:  2017-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.